Harrow, Inc.
HROW
#5369
Rank
NZ$2.74 B
Marketcap
NZ$73.55
Share price
-2.01%
Change (1 day)
23.19%
Change (1 year)

Earnings for Harrow, Inc. (HROW)

Earnings in 2026 (TTM): NZ$19.44 Million

According to Harrow, Inc.'s latest financial reports the company's current earnings are NZ$0.26 Billion. In 2025 the company made an earning of NZ$39.17 Million, an increase over its 2024 earnings that were of NZ$9.38 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Harrow, Inc. from 2007 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) NZ$19.44 M-50.37%
2025 NZ$39.17 M317.34%
2024 NZ$9.38 M-329.09%
2023 -NZ$4.1 Million-224.34%
2022 NZ$3.29 M3.01%
2021 NZ$3.19 M149.06%
2020 NZ$1.28 M434.29%
2019 NZ$0.24 M-102.68%
2018 -NZ$8.96 Million-57.11%
2017 -NZ$20.89 Million-21.93%
2016 -NZ$26.76 Million5.11%
2015 -NZ$25.46 Million46.16%
2014 -NZ$17.42 Million32.68%
2013 -NZ$13.13 Million42.63%
2012 -NZ$9.21 Million
2010 -NZ$4.26 Million-45.76%
2009 -NZ$7.84 Million21.83%
2008 -NZ$6.44 Million-491.97%
2007 NZ$1.64 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-NZ$0.4 Billion-2,013.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-NZ$31.18 Million-251.76%๐Ÿ‡บ๐Ÿ‡ธ USA